Eclipsebio
PrivateLast Round
Grant
Jan 13, 2025
Total Funding Raised
$19.32M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Eclipsebio is a biotechnology company that develops first-in-class technologies, analyses, and platforms for the development of RNA-based and RNA-targeting therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eclipsebio Comparables
Compare Eclipsebio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alida Biosciences | 84% | |
| Atomic AI | 83% | |
| Envisagenics | 81% | |
Eclipsebio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 13, 2025 | ||||
| Grant | Jul 1, 2024 | ||||
| Series A | Mar 15, 2022 | ||||
| Seed | Jun 5, 2020 | ||||
| Grant | Sep 17, 2019 | ||||
Grant | Sep 20, 2017 |
Eclipsebio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Series A |
| NIH RADx | Grant |
| Alexandria Venture Investments | Series A |
| iGlobe Partners | Series A |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched eCOMPASS platform for AI-driven RNA therapeutic development.
- Jan 26, 2026
Acquired Terrain Biosciences to advance RNA therapeutic design.
Eclipsebio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eclipsebio's valuation, stock price, and market status.